Sp. Ho et al., Regulation of the angiotensin type-1 receptor by antisense oligonucleotides occurs through an RNase H-type mechanism, MOL BRAIN R, 65(1), 1999, pp. 23-33
Multiple, diverse sites in the coding region of the angiotensin type-1 rece
ptor mRNA were targeted with 2'-deoxyribonucleotide antisense oligonucleoti
des (ONs). The uptake of 1 mu M concentration of these ONs into Chinese ham
ster ovary cells was facilitated by the use of cationic liposomes. The anti
sense sequences reduced binding of I-125-angiotensin II by 57-73%, while mi
smatch ONs and reverse sequence ONs produced little reduction in receptor b
inding. These reductions in AT(1) receptor binding were accompanied by comp
arable decreases in AT(1) receptor mRNA levels. Furthermore, mRNA cleavage
fragments corresponding in size to 3'-cleavage fragments were observed with
two of the antisense ONs, consistent with the involvement of an RNase H-ty
pe enzyme. When 2'-methoxyribonucleotide analogs of these same sequences we
re tested, AT(1) receptor mRNA levels were unchanged even though small redu
ctions in AngII binding were observed. Antisense effects seen with these 2'
-methoxyribonucleotide sequences may have arisen through a translational ar
rest mechanism. Direct comparisons between 2'-deoxyribonucleotide analogs a
nd their 2'-methoxyribonucleotide counterparts show that antisense effects
are significantly larger when they are mediated through an RNase H-type mec
hanism. 2'-methoxyribonucleotide sequences were most effective when they we
re directed against the translation initiation codon. (C) 1999 DuPont Pharm
aceuticals Company. Published by Elsevier Science B.V.